Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hypokalemia causes a significant decrease in the tonicity of the renal medullary interstitium in association with reduced expression of sodium transporters in the distal tubule. We asked whether hypokalemia caused downregulation of the
tonicity-responsive enhancer binding protein
(
TonEBP
)
transcriptional activator
in the renal medulla due to the reduced tonicity. We found that the abundance of
TonEBP
decreased significantly in the outer and inner medullas of hypokalemic rats. Underlying mechanisms appeared different in the two regions because the abundance of
TonEBP
mRNA was lower in the outer medulla but unchanged in the inner medulla. Immunohistochemical examination of
TonEBP
revealed cell type-specific differences.
TonEBP
expression decreased dramatically in the outer and inner medullary collecting ducts, thick ascending limbs, and interstitial cells. In the descending and ascending thin limbs,
TonEBP
abundance decreased modestly. In the outer medulla,
TonEBP
shifted to the cytoplasm in the descending thin limbs. As expected, transcription of aldose reductase, a target of
TonEBP
, was decreased since the abundance of mRNA and protein was reduced. Downregulation of
TonEBP
appeared to have also contributed to reduced expression of aquaporin-2 and UT-A urea transporters in the renal medulla. In cultured cells, expression and activity of
TonEBP
were not affected by reduced potassium concentrations in the medium. These data support the view that medullary tonicity regulates expression and nuclear distribution of
TonEBP
in the renal medulla in cell type-specific manners.
...
PMID:Downregulation of renal TonEBP in hypokalemic rats. 1740 77
The
TonE-binding protein
(
TonEBP
) is a
transcriptional activator
in the Rel family that includes NFkappaB and NFAT.
TonEBP
is critical for the development and function of the renal medulla, which is a major regulator of water homeostasis.
TonEBP
is also implicated in diabetic nephropathy and inflammation. Established methods for biochemical and histochemical detection and functional analysis of
TonEBP
, including identification of novel
TonEBP
target genes, are described for those who are interested in investigating function and regulation of
TonEBP
.
...
PMID:Transcriptional activator TonE-binding protein in cellular protection and differentiation. 1787 22
During antidiuresis, renal medullary cells adapt to the hyperosmotic interstitial environment by increased expression of osmoprotective genes, which is driven by a common
transcriptional activator
,
tonicity-responsive enhancer binding protein
(
TonEBP
). Because nitric oxide (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and
TonEBP
activation in MDCK cells. Several structurally unrelated NO donors blunted tonicity-induced up-regulation of
TonEBP
target genes involved in intracellular accumulation of organic osmolytes. These effects were mediated by reduced transcriptional activity of
TonEBP
, as assessed by tonicity-responsive elements- and aldose reductase promoter-driven reporter constructs. Neither total
TonEBP
abundance nor nuclear translocation of
TonEBP
was affected by NO. Furthermore, 8-bromo-cGMP and peroxynitrite failed to reproduce the inhibitory effect of NO, indicating that NO acts directly on
TonEBP
rather than through classical NO signaling pathways. In support of this notion, electrophoretic mobility shift assays showed reduced binding of
TonEBP
to its target sequence in nuclear extracts prepared from MDCK cells treated with NO in vivo and in nuclear extracts exposed to NO in vitro. Furthermore, immunoprecipitation of S-nitrosylated proteins and the biotin-switch method identified
TonEBP
as a target for S-nitrosylation, which correlates with reduced DNA binding and transcriptional activity. These observations disclose a novel direct inhibitory effect of NO on
TonEBP
, a phenomenon that may be relevant for regulation of osmoprotective genes in the renal medulla.
...
PMID:Nitric oxide decreases expression of osmoprotective genes via direct inhibition of TonEBP transcriptional activity. 1856 63
The renal cortico-papillary osmotic gradient is generated by sodium reabsorption in the thick ascending limb. The antidiuretic hormone arginine vasopressin (AVP) increases collecting duct water permeability by enhancing aquaporin-2 (AQP2) water channel insertion in the apical membrane of principal cells, allowing water to passively flow along the osmotic gradient from the tubule lumen to the interstitium. In addition to short-term AQP2 redistribution between intracellular compartments and the cell surface, AQP2 whole cell abundance is tightly regulated. AVP is a major
transcriptional activator
of the AQP2 gene, and stimulation of insulin- and calcium-sensing receptors respectively potentiate and reduce its action. Extracellular tonicity is another key factor that determines the levels of AQP2 abundance. Its effect is dependent on activation of the
tonicity-responsive enhancer binding protein
that reinforces AVP-induced AQP2 transcriptional activation. Conversely, activation of the NF-kappaB transcriptional factor by proinflammatory factors reduces AQP2 gene transcription. Aldosterone additionally regulates AQP2 whole cell abundance by simultaneously reducing AQP2 gene transcription and stimulating AQP2 mRNA translation. These examples illustrate how cross talk between various stimuli regulates AQP2 abundance in collecting duct principal cells and consequently contributes to maintenance of body water homeostasis.
...
PMID:Aquaporin-2 abundance in the renal collecting duct: new insights from cultured cell models. 1924 7